Mariano Dioca

🚨 The biggest breakthrough in pancreatic cancer in more than a decade. At the ASCO 2026 Plenary Session, the phase III RASolute 302 trial showed that daraxonrasib nearly doubled overall survival in previously treated pancreatic cancer @EMOGI_AAOC #ASCO2026 #PancreaticCancer

The CHALLENGE trial forces a rethink. In early-stage CCR , a structured exercise program was tested vs standard follow-up. The intervention was supervised, structured, physical activity . A behavioral intervention that may be part of the therapeutic arsenal. #ASCO2026

Today, the final analysis of BREAKWATER Cohort 3 confirmed a significant PFS benefit and encouraging overall survival with encorafenib + cetuximab + FOLFIRI in the first-line treatment of BRAF V600E-mutant metastatic CRC . EMOGI Argentina AAOC AsocArgOncoClínica #ASCO2026

Asco te permite encontrarte con amigos que aún viviendo en el mismo pueblo el tiempo no te permite ver ! Que bueno verte @barrosonco maco acá en Chicago !! #ASCO2026

Are we ready to move sistemic treatment for intermediate HCC in combination with tace ? Probably no yet !! @ASCO @EMOGI_AAOC

Gracias a los colegas de Montevideo por compartir su experiencia en cancer colorrectal inestable la semana pasada , gran intercambio con amigos de muchos años !

Gracias @merckgroup por la invitación ! Gracias a todos los amigos y colegas de Cordoba . #cancer colorrectal #braf mutant

Great experience at @SLAGO 🇨🇱 as speaker and session co-chair. Honored to collaborate with @Julieta Grasselli and @Ana de Jesus Acosta. Thanks to Dr. Jorge Gallardo for building such a key platform for GI oncology in Latin America. #SLAGO #Oncology #LatAm

Gracias @knight therapeutics por la invitación para hablar anoche sobre pemigatinib en colangiocarcinoma , gracias a @EMOGI_AAOC por estar presente y a mi excelente co -equíper @luciana belaquero !

Muchas gracias @aaoncoclinica por la invitación a esta nueva edición del Post asco GUGi en Bariloche , clásico de gran nivel al que por otros compromisos no logré asistir en forma presencial pero fue placer poder presentar avances de Cancer de páncreas. @EMOGI_AAOC .

#Colorectal MiNEN: Data at #ENETS2026 support dynamic interplay between adenocarcinoma and neuroendocrine components, reinforcing tumor plasticity and possible shared clonal origin. Important implications for tumor biology and treatment strategies. #NET #MiNEN #ENETS2026

Preclinical data support the development of SSTR-targeted antibody–drug conjugates (ADCs) in NETs. While clinical data in humans are still lacking, the biological rationale and early models are promising. #ENETS2026

At #ENETS2026 in Kraków 🇵🇱 The 2L+ landscape in NETs keeps expanding. Cabozantinib emerging as a key option across multiple NET subtypes after prior therapies. Exciting shift toward more effective targeted strategies. #NETs #NeuroendocrineTumors #Oncology

Great to see these data presented at #ENETS2026. Special thanks to the investigators across LATAM whose collaboration made this study possible. Multinational teamwork continues to drive progress in NET research. @RachelRiechelm2 @Nanodioca @draanyoviedo 🇦🇷🇧🇷

The Argentine group in Krakow #ENETS2026 Looking forward to a great meeting and discussions on NETs @Nanodioca @fabianamarmissolle @draanyoviedo 🇦🇷

Ayudante de primera dedicación simple (10 horas semanales de clases) y 17 años de antigüedad en la UBA. ¡Cumplan la Ley de Financiamiento Universitario!

Exploratory biomarkers analyses from the phase 2 Study With paltusotine . Póster presentation @asco GI 2026 San Francisco. @Crinetics @AnaIsabelOviedo @RachelRiechelm2 @JuanOConnorA

HERIZON-GEA-01 at #ASCOGI2026: Zanidatamab + chemo (± PD-1) outperformed trastuzumab in 1L HER2+ GEA, with significant PFS and OS benefit. Dual-epitope HER2 targeting may represent a true paradigm shift. #ASCOGI2026 #GastricCancer #HER2 #Zanidatamab

Un honor y un placer haber participado como speaker en el acho hace unos días atrás con colegas y amigos en Cartagena , siempre es una alegria volver a Colombia !! , gracias a los organizadores por la invitación!! #cancer gástrico #acho

🌍 Exciting days at @Esmo in Berlin, It’s inspiring to exchange ideas with colleagues from around the world and explore the latest advances in cancer research and treatment. #ESMO2025 #Oncology #CancerResearch #MedicalOncology #Berlin #EMOGI